Literature DB >> 15307838

Diminishing significance of HLA matching in kidney transplantation.

Xuanming Su1, Stefanos A Zenios, Harini Chakkera, Edgar L Milford, Glenn M Chertow.   

Abstract

To determine trends in the significance of HLA matching and other risk factors in kidney transplantation, we analyzed data on graft survival in a consecutive sample of 33 443 transplant recipients who received deceased donor kidneys from December 1994 to December 1998 with a mean follow-up time of 2.2 years. HLA matching and other risk factors (peak panel reactive antibody, donor age, sex and cause of death, cold ischemia time, donor and recipient body size) were examined. Mean likelihood ratios of models, fit with and without each variable of interest, were calculated by generating bootstrapped samples from each single year cohort. Pooled censored and uncensored graft survival rates were 90.6% and 89.9% at 1 year, 85.8% and 84.5% at 2 years, and 80.7% and 78.6% at 3 years. HLA matching declined in significance while other factors retained similar levels of statistical significance over the four yearly cohorts. With evolving clinical practice, including the provision of safer and more potent immunosuppressive therapy, the significance of HLA matching has diminished. Non-immunologic factors continue to impede more marked improvements in long-term graft survival. Recognizing these trends, organ allocation algorithms may need to be revised. Copyright 2004 Blackwell Munksgaard

Entities:  

Mesh:

Year:  2004        PMID: 15307838     DOI: 10.1111/j.1600-6143.2004.00535.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  23 in total

1.  Kidneys for transplant.

Authors:  Colin C Geddes; R Stuart C Rodger
Journal:  BMJ       Date:  2006-05-13

2.  The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors.

Authors:  Robert C Williams; Gerhard Opelz; Chelsea J McGarvey; E Jennifer Weil; Harini A Chakkera
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

3.  HLA-DRB1 and susceptibility to kidney allograft rejection in Southern Iranian patients.

Authors:  Behrouz Gharesi-Fard; Leila Rezanezhad; Mohammad Hossein Karimi; Bita Geramizadeh; Mohammad Mehdi Salehipour; Seyed Ali Malek Hosseini; Jamshid Roozbeh
Journal:  Mol Biol Rep       Date:  2014-06-06       Impact factor: 2.316

4.  Whether or not to accept a deceased donor kidney offer for a pediatric patient.

Authors:  Abanti Chaudhuri; Gerri James; Paul Grimm
Journal:  Pediatr Nephrol       Date:  2015-07-01       Impact factor: 3.714

5.  Are there good reasons for inequalities in access to renal transplantation in children?

Authors:  Julien Hogan; Benoit Audry; Jérôme Harambat; Olivier Dunand; Arnaud Garnier; Rémi Salomon; Tim Ulinski; Marie-Alice Macher; Cécile Couchoud
Journal:  Nephrol Dial Transplant       Date:  2014-11-23       Impact factor: 5.992

6.  Inferior allograft outcomes in adolescent recipients of renal transplants from ideal deceased donors.

Authors:  Matthew H Levine; Peter P Reese; Alexander Wood; Jorge H Baluarte; Ari Huverserian; Ali Naji; Peter L Abt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

7.  Genetic determinants of renal transplant outcome: where do we stand?

Authors:  Paul J Phelan; Peter J Conlon; Matthew A Sparks
Journal:  J Nephrol       Date:  2014-02-11       Impact factor: 3.902

8.  Is matching for human leukocyte antigen-DR beneficial in pediatric kidney transplantation?

Authors:  Mohamed A Ghoneim; Ayman F Refaie
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

9.  Outcomes of kidney transplant tourism in children: a single center experience.

Authors:  Abdul Majid; Lina Al Khalidi; Bushra Q Ahmed; Gerhard Opelz; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2009-09-01       Impact factor: 3.714

10.  Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients.

Authors:  Domingo Hernández; Teresa Vázquez; Juana Alonso-Titos; Myriam León; Abelardo Caballero; María Angeles Cobo; Eugenia Sola; Verónica López; Pedro Ruiz-Esteban; Josep María Cruzado; Joana Sellarés; Francesc Moreso; Anna Manonelles; Alberto Torio; Mercedes Cabello; Juan Delgado-Burgos; Cristina Casas; Elena Gutiérrez; Cristina Jironda; Julia Kanter; Daniel Serón; Armando Torres
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.